{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:19:30Z","timestamp":1773364770626,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068633, UM1AI068615, UM1AI106707"],"award-info":[{"award-number":["UM1AI068633, UM1AI068615, UM1AI106707"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10461-022-03745-y","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T16:09:48Z","timestamp":1654618188000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and Action of the Dapivirine Vaginal Ring as Understood by Women Participating in an Open Label Extension Study"],"prefix":"10.1007","volume":"27","author":[{"given":"Kalendri","family":"Naidoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montgomery Elizabeth","family":"T.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana WK.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garcia","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reddy","family":"Krishnaveni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soto-Torres","family":"Lydia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naidoo","family":"Sarita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansoor E.","family":"Leila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"3745_CR1","unstructured":"UNAIDS. Fact sheet 2021, preliminary UNAIDS 2021 epidemiological estimates. Available at: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf."},{"key":"3745_CR2","doi-asserted-by":"crossref","unstructured":"Mash R, Mash B, de Villiers P. \u2018Why don\u2019t you just use a condom?\u2019: Understanding the motivational tensions in the minds of South African women. Afr J Prim Health Care Fam Med. 2010; 2(1), Art. #79, 4 pages.","DOI":"10.4102\/phcfm.v2i1.79"},{"key":"3745_CR3","doi-asserted-by":"crossref","unstructured":"Hlongwa M, Peltzer K, Hlongwana K. Risky sexual behaviours among women of reproductive age in a high HIV burdened township in KwaZulu-Natal, South Africa. BMC Infect Dis. 2020; 20, 563.","DOI":"10.1186\/s12879-020-05302-1"},{"key":"3745_CR4","doi-asserted-by":"publisher","first-page":"2,109","DOI":"10.2989\/16085906.2016.1196224","volume":"15","author":"C Baxter","year":"2016","unstructured":"Baxter C, Abdool Karim S. Combination HIV prevention options for young women in Africa. Afr J AIDS Res. 2016;15:2,109\u201321.","journal-title":"Afr J AIDS Res"},{"issue":"22","key":"3745_CR5","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375(22):2121\u201332.","journal-title":"N Engl J Med"},{"key":"3745_CR6","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","volume":"375","author":"A Nel","year":"2016","unstructured":"Nel A, van Niekerk N, Kapiga S, et al. Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. N Engl J Med. 2016;375:2133\u201343.","journal-title":"N Engl J Med"},{"issue":"2","key":"3745_CR7","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/S2352-3018(20)30304-0","volume":"8","author":"JM Baeten","year":"2021","unstructured":"Baeten JM, Palanee-Phillips T, Mgodi NM, et al. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. Lancet HIV. 2021;8(2):e87\u201395.","journal-title":"Lancet HIV"},{"issue":"2","key":"3745_CR8","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/S2352-3018(20)30300-3","volume":"8","author":"A Nel","year":"2021","unstructured":"Nel A, van Niekerk N, Van Baelen B, et al. Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study. Lancet HIV. 2021 Feb;8(2):e77\u201386.","journal-title":"Lancet HIV"},{"key":"3745_CR9","unstructured":"Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring: March 2021. Geneva: World Health Organization; 2021."},{"key":"3745_CR10","unstructured":"Gwarisa M. #BREAKING: Dapivirine, Vaginal Ring Approved For Use In Zimbabwe. 2021; https:\/\/healthtimes.co.zw\/2021\/07\/14\/breaking-dapivirine-vaginal-ring-approved-for-use-in-zimbabwe\/. Accessed July 27, 2021."},{"key":"3745_CR11","unstructured":"Fokazi S. More HIV prevention options for SA women as vaginal ring is approved. 2022; https:\/\/www.timeslive.co.za\/news\/south-africa\/2022-03-16-more-hiv-prevention-options-for-sa-women-as-vaginal-ring-approved\/. Accessed March 25, 2022."},{"issue":"4","key":"3745_CR12","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1097\/QAI.0000000000002590","volume":"86","author":"K Naidoo","year":"2021","unstructured":"Naidoo K, Mansoor LE, Katz AWK, et al. Qualitative Perceptions of dapivirine VR adherence and drug level feedback following an open-label extension trial. J Acquir Immune Defic Syndr. 2021;86(4):e90\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"3745_CR13","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1007\/s10461-020-03119-2","volume":"25","author":"ET Montgomery","year":"2021","unstructured":"Montgomery ET, Katz AWK, Duby Z, et al. Men\u2019s Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav. 2021 Jun;25(6):1890\u2013900.","journal-title":"AIDS Behav"},{"issue":"16","key":"3745_CR14","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1097\/QAD.0000000000000801","volume":"29","author":"A Van der Straten","year":"2015","unstructured":"Van der Straten A, Montgomery ET, Musara P, et al. Disclosure of pharmacokinetic drug results to understand nonadherence. AIDS. 2015;29(16):2161\u201371.","journal-title":"AIDS"},{"issue":"1","key":"3745_CR15","doi-asserted-by":"publisher","first-page":"18505","DOI":"10.7448\/IAS.16.1.18505","volume":"16","author":"C Woodsong","year":"2013","unstructured":"Woodsong C, MacQueen K, Amico KR, et al. Microbicide clinical trial adherence: insights for introduction. J Int AIDS Soc. 2013;16(1):18505.","journal-title":"J Int AIDS Soc"},{"issue":"3Suppl 2","key":"3745_CR16","first-page":"19419","volume":"17","author":"CW Geary","year":"2014","unstructured":"Geary CW, Bukusi EA. Women and ARV-based prevention: opportunities and challenges. J Int AIDS Soc. 2014;17(3Suppl 2):19419.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"3745_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10461-020-03011-z","volume":"25","author":"IC Bal\u00e1n","year":"2021","unstructured":"Bal\u00e1n IC, Giguere R, Lentz C, et al. Client-centered adherence counseling with adherence measurement feedback to support use of the dapivirine ring in MTN-025 (The HOPE Study). AIDS Behav. 2021;25(2):447\u201358.","journal-title":"AIDS Behav"},{"issue":"Suppl 4","key":"3745_CR18","doi-asserted-by":"crossref","first-page":"e25298","DOI":"10.1002\/jia2.25298","volume":"22","author":"CL Celum","year":"2019","unstructured":"Celum CL, Delany-Moretlwe S, Baeten JM, et al. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery. J Int AIDS Soc. 2019;22(Suppl 4(Suppl Suppl 4):e25298.","journal-title":"J Int AIDS Soc"},{"issue":"Suppl 4","key":"3745_CR19","doi-asserted-by":"crossref","first-page":"e25306","DOI":"10.1002\/jia2.25306","volume":"22","author":"R Eakle","year":"2019","unstructured":"Eakle R, Weatherburn P, Bourne A. Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa. J Int AIDS Soc. 2019;22(Suppl 4(Suppl Suppl 4):e25306.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"3745_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11904-007-0024-7","volume":"4","author":"LA Eaton","year":"2007","unstructured":"Eaton LA, Kalichman S. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Curr HIV\/AIDS Rep. 2007;4(4):165\u201372.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"Suppl Suppl 6","key":"3745_CR21","doi-asserted-by":"crossref","first-page":"e25351","DOI":"10.1002\/jia2.25351","volume":"22","author":"D Rojas Castro","year":"2019","unstructured":"Rojas Castro D, Delabre RM, Molina JM. Give PrEP a chance: moving on from the \u201crisk compensation\u201d concept. J Int AIDS Soc. 2019;22(Suppl Suppl 6):e25351. Suppl 6(.","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"3745_CR22","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s10461-019-02720-4","volume":"24","author":"KF Ortblad","year":"2020","unstructured":"Ortblad KF, Stalter RM, Bukusi EA, et al. No Evidence of Sexual Risk Compensation Following PrEP Initiation Among Heterosexual HIV Serodiscordant Couples in Kenya and Uganda. AIDS Behav. 2020 May;24(5):1365\u201375.","journal-title":"AIDS Behav"},{"issue":"1","key":"3745_CR23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/sextrans-2020-054718","volume":"98","author":"S Kusemererwa","year":"2022","unstructured":"Kusemererwa S, Abaasa A, Kabarambi A, Onyango M, Mugisha JO. Assessment of risk compensation following use of the dapivirine vaginal ring in southwestern Uganda. Sex Transm Infect. 2022;98(1):32\u20137.","journal-title":"Sex Transm Infect"},{"issue":"12","key":"3745_CR24","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s40265-019-01143-8","volume":"79","author":"I Hodges-Mameletzis","year":"2019","unstructured":"Hodges-Mameletzis I, Fonner VA, Dalal S, Mugo N, Msimanga-Radebe B, Baggaley R. Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Status and Future Directions. Drugs. 2019;79(12):1263\u201376.","journal-title":"Drugs"},{"issue":"5","key":"3745_CR25","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s10461-014-0950-5","volume":"19","author":"ET Montgomery","year":"2015","unstructured":"Montgomery ET, van der Straten A, Stadler J, et al. Male Partner Influence on Women\u2019s HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of \u201cUnderstanding\u201d. AIDS Behav. 2015;19(5):784\u201393.","journal-title":"AIDS Behav"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-022-03745-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-022-03745-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-022-03745-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T19:52:29Z","timestamp":1700682749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-022-03745-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["3745"],"URL":"https:\/\/doi.org\/10.1007\/s10461-022-03745-y","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,7]]},"assertion":[{"value":"29 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The MTN-032\/Assessment of ASPIRE and HOPE Adherence (AHA) study was designed and implemented by the Microbicide Trials Network (MTN). The MTN is funded by the National Institute of Allergy and Infectious Diseases (UM1AI068633, UM1AI068615, UM1AI106707), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the United States (US) National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The vaginal rings used in this study were supplied by the International Partnership for Microbicides (IPM).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Source of funding"}},{"value":"The MTN 032 study protocol was approved by the Institutional Review Boards at RTI International, and at each study site and regulated by the U.S. National Institutes of Health and the Microbicide Trials Network.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All participants were informed that any publication of this study will not use their name or identify them personal.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}